Introduction: The Convergence of Utilitarian Maximization and Public Health Containment
Modern administrative jurisprudence and contemporary public health governance derive much of their normative legitimacy from positivistic utilitarianism1. Under this welfarist paradigm, institutional interventions are justified by their capacity to maximize an aggregated scalar quantity of social utility across a designated population1. In clinical addiction medicine and federal healthcare policy, this ethos is embodied in the widespread implementation of Medications for Opioid Use Disorder (MOUD)—principally methadone, buprenorphine, and extended-release naltrexone—which function as harm-reduction mechanisms calibrated to suppress fatal overdoses, curtail transmission of blood-borne pathogens, and reduce societal expenditures2. Concurrently, within formal social choice theory and legal philosophy, the framework of Maximizing Overall Utility and Distribution (MOUD logic) denotes an unconstrained sum-maximization calculus applied to variable-population states1.
Despite producing marked short-term reductions in all-cause and overdose-specific mortality during active clinical maintenance, policies centered strictly on utilitarian aggregation encounter severe structural failures2. When evaluated against the formal axiological impossibility theorems developed by Gustaf Arrhenius, unconstrained welfare-maximization systems are mathematically incapable of satisfying basic, mutually compatible criteria of distributive adequacy1. Most notably, they succumb to the Repugnant Conclusion, wherein an institutional framework favors expanding a vast population living in states of marginal, near-subsistence quality of life over cultivating a smaller, flourishing society1.
This theoretical pathology maps directly onto the empirical realities of opioid pharmacotherapy2. By operating primarily as an operational buffer rather than a curative transformation, MOUD establishes a dynamic of intervenor dependence that mirrors the “Shifting the Burden” systems archetype2. The resulting clinical equilibrium expands a vulnerable cohort whose survival depends entirely on uninterrupted chemical stabilization, while systemic capacity for fundamental recovery atrophies2. Analyzing these convergent failures reveals how scalar welfare summation inevitably breaks down in dynamic population environments, highlighting the necessity of an axiomatic reconstruction grounded in priority-sensitive, rights-based, and procedural governance1.
Mathematical Foundations of Utilitarian Aggregation and Informational Invariance
Positivistic utilitarianism conceptualizes legal institutions, administrative rules, and clinical delivery systems as optimization functions engineered to compute collective well-being1. Formally, let denote a finite set of individuals, and let denote a set of mutually exclusive social states1. The private welfare of each agent is characterized by an individual utility function 1. Under Expected Utility Theory, as axiomatized by John von Neumann and Oskar Morgenstern, agent preferences over lotteries on are represented by affine utility functions where the utility of a probability distribution is its expected value1:
To aggregate these private valuations into a collective preference ordering, administrative systems utilize a Social Welfare Functional (SWFL), defined as a mapping , where is the profile of individual utility functions and is the space of complete, transitive social preference orderings over 1. Under Harsanyi’s Aggregation Theorem, if the collective preference ordering satisfies the von Neumann-Morgenstern rationality axioms alongside the principle of Pareto Indifference—which mandates that if all individuals are indifferent between two states, society must be indifferent—then the social welfare functional must be expressed as an affine combination of individual utilities1:
where represents the welfare weight assigned to agent , and is an arbitrary origin parameter1. In classical total utilitarianism, anonymity and impartiality force uniform weighting () and normalization (), yielding the canonical sum-maximization rule1:
The informational invariance classification established by Claude d’Aspremont and Louis Gevers reveals that this sum-maximization framework relies fundamentally on Cardinal Unit Comparability (IOU)1. Under IOU, individual utility functions are invariant under positive affine transformations sharing a common strictly positive scaling factor , expressed as 1. While IOU permits the aggregation of welfare differences across individuals, it strictly prohibits the comparison of absolute welfare levels between distinct agents due to the arbitrary, person-specific shift parameters 1.
Consequently, an administrative system governed by MOUD logic cannot structurally evaluate whether an individual sits above or below an absolute deprivation threshold1. It evaluates institutional interventions solely on the basis of aggregate scalar deltas, treating welfare gains and losses across distinct persons as fungible components of a single composite ledger1.
Arrhenius’ Axiological Impossibilities and the Mechanics of Repugnance
When total utilitarian aggregation is applied to dynamic or variable-population spaces—where policy choices alter not only the welfare of existing agents but also the number and identity of individuals who exist—the framework collapses into intractable axiological paradoxes1. In Future Generations: A Challenge for Moral Theory, Gustaf Arrhenius demonstrated through a sequence of formal impossibility proofs that no population axiology can simultaneously satisfy a set of minimal, intuitive adequacy conditions4.
Derek Parfit initially formulated the Repugnant Conclusion as a direct consequence of total utilitarianism, demonstrating that for any possible population of individuals enjoying a very high quality of life, there must be some much larger imaginable population whose existence is better even though its members have lives that are barely worth living1. Formally, consider a population of size where each individual enjoys a high positive utility level , and an alternative population of size where each individual exists at a marginally positive welfare level , such that 1. Under total utilitarian sum-maximization, the social evaluations of the two states are given by and 1. Because real numbers obey the Archimedean property, for any finite values of , , and , there exists an integer such that1:
Consequently, the utilitarian framework demands that population be judged strictly better than population , compelling the social planner to favor sheer demographic dilution over flourishing human existence1. To overcome standard non-Archimedean objections, Arrhenius formulated more potent generalizations, notably the Very Repugnant Conclusion (VRC)5. The VRC establishes that for any perfectly equal population with very high positive welfare, and for any number of lives with very negative welfare, there exists a population consisting of the suffering lives alongside an expansive number of lives with very low positive welfare that is judged morally superior to the high-welfare population alone5. In the VRC, a large enough addition of lives barely worth living is held to compensate not only for the forfeiture of a flourishing society, but also for the co-presence of arbitrary amounts of horrific suffering5.
Arrhenius proved that avoiding these conclusions while preserving basic ethical axioms is mathematically impossible1. His Sixth Impossibility Theorem demonstrates the mutual incompatibility of several minimal conditions6:
The Additive Anti-Repugnance Condition requires that a population containing excellent lives must always make a better addition to a state of affairs than an arbitrarily large population of lives barely worth living, particularly when accompanied by severe suffering1. The Weak Quality Addition (WQA) condition dictates that for any population , there exists an equal population with very high positive welfare, a very negative welfare level, and a finite number of lives at this negative level, such that adding the high-welfare population to is at least as good as adding any population with low positive welfare alongside the suffering lives5. Total utilitarianism directly violates WQA because an expansive enough addition of near-subsistence lives will eventually outweigh any fixed quantity of suffering and high-welfare lives5.
The General Non-Extreme Priority (GNEP) condition mandates that an extreme welfare sacrifice by a single worse-off agent cannot be endlessly justified by conferring microscopic benefits upon a massive cohort of already well-off agents1. The Weak Non-Sadism (WNS) condition establishes that there is a negative welfare level and a number of lives at this level such that adding any number of people with positive welfare is at least as good as adding those suffering lives8. The Non-Elitism and Egalitarian Dominance conditions dictate that if population is identical in size to population and every person in has strictly higher welfare than every person in , then must be ranked better than , and that concentrating extreme welfare in a single individual cannot dominate an equal distribution that sits marginally below that individual’s apex8. Finally, Finite Fine-Grainedness (FFG) assumes that there exists a finite sequence of slight, barely perceptible welfare differences connecting any very positive welfare level to a very negative welfare level9. Because FFG guarantees that welfare states can be connected via a continuous chain of marginal steps, repeatedly applying standard same-people trade-offs forces an intransitivity or contradicts one of the dominance conditions, creating an inescapable axiomatic impossibility6.
Structural Mapping: Instantiating Population Paradoxes in MOUD Regimes
The structural pathologies identified in Arrhenius’ theorems are not merely theoretical abstractions; they are directly instantiated in public health systems governed by MOUD logic1. When administrative agencies prioritize scalar welfare aggregation—measured primarily via fatal overdoses averted, emergency room visits suppressed, and direct medical cost offsets—they inadvertently reconstruct the conditions of the Repugnant Conclusion2.
| Axiological Adequacy Condition (Arrhenius) | Theoretical Pathology of Total Utilitarianism | Real-World Operationalization in MOUD Systems |
| Avoidance of the Repugnant Conclusion (RC)[cite: 1, 5] | Prefers a massive population at near-zero utility () over a smaller, flourishing population ()1. | Low-barrier agonist therapy expands a large cohort maintained in “pharmacological containment,” stabilizing biological survival while leaving individuals in chronic social distress2. |
| Weak Quality Addition (WQA)[cite: 5, 8] | Violates the requirement that adding flourishing lives dominates adding near-subsistence lives alongside severe suffering5. | Resources are directed toward rapid medication onboarding rather than intensive residential rehabilitation or psychiatric healing, tolerating horrific post-cessation tail risks2. |
| General Non-Extreme Priority (GNEP)[cite: 1, 8] | Allows minor gains accrued across a vast population to outweigh catastrophic harm inflicted on worse-off agents1. | Administrative decisions optimize overall system-level throughput and fiscal cost containment while exposing unstable out-of-treatment individuals to lethal cessation risks2. |
| Non-Elitism / Egalitarian Dominance[cite: 8, 9] | Evaluates welfare sums independently of equitable distributive baselines, risking extreme utility concentration1. | Programs measure aggregate retention headcounts and gross survival, disregarding stark qualitative disparities between biological stability and comprehensive recovery2. |
| Finite Fine-Grainedness (FFG)[cite: 9, 11] | Assumes smooth, marginal transitions between welfare levels, producing non-transitive or repugnant rankings6. | Clinical policies treat incremental harm reduction as continuous, overlooking the severe discontinuous drop in tolerance and heightened mortality risk when treatment is interrupted2. |
In practical health policy, MOUD functions as an operational buffer rather than a curative transformation2. Clinical data confirms that while patients are actively retained on opioid agonists, all-cause mortality is cut by more than half (Relative Risk, ; 95% Confidence Interval [CI]: 0.42–0.53)2. The medications bind to -opioid receptors, mitigating withdrawal symptoms, blunting cravings, and establishing cross-tolerance that protects against fatal respiratory depression from illicit fentanyl2.
However, MOUD does not resolve underlying neurochemical dysregulation, co-occurring psychiatric disorders, deep psychosocial trauma, or profound economic marginalization2. A utilitarian governance framework focused strictly on aggregate life-years treats biological survival under pharmacological containment as a self-sufficient social good2. The resulting institutional equilibrium expands a large stock of maintained individuals who survive at a marginal, near-subsistence quality of life (), rather than investing resources to cultivate comprehensive recovery, psychological sovereignty, and socio-economic integration ()1. This dynamic recreates the demographic dilution of the Repugnant Conclusion: public policy prioritizes expanding the total number of chemically maintained person-months over building pathways to high-functioning autonomy or genuine flourishing1.
Furthermore, total utilitarianism violates Arrhenius’ Weak Quality Addition condition because it permits an expansive addition of lives barely worth living to mathematically offset severe suffering and the elimination of excellent lives5. In the context of MOUD, the system tolerates acute, catastrophic risks imposed upon individuals who exit the treatment buffer in exchange for expanding aggregate on-treatment tallies2. Because public health budgets operate under hard resource constraints, the rapid expansion of low-threshold dispensing diverts clinical capital, staffing, and Medicaid funding away from intensive dual-diagnosis psychiatric care, restorative residential facilities, and long-term vocational rehabilitation2. The system accepts an operational regime characterized by steep attrition rates—where more than 47% of patients drop out within 12 to 18 months—because the aggregate sum of saved life-years during active months outweighs the unmeasured human wreckage that follows treatment cessation2.
Arrhenius’ General Non-Extreme Priority condition mandates that an institutional framework must not sacrifice the vital interests of the most severely disadvantaged individuals merely to deliver marginal, diffuse benefits to a broad population1. MOUD-dominated models violate this principle by design1. The broader community benefits from reduced public injection, suppressed criminal activity, lower municipal policing costs, and diminished emergency response outlays2. Yet these diffuse social gains are achieved by placing people with opioid use disorder into an intervenor-dependent pipeline where a single point of administrative failure—such as clinic expulsion, missed daily dosing windows, or arrest—exposes the individual to extreme rebound mortality2. The acute, concentrated risk of death borne by the vulnerable individual is treated as a tolerable externality within the aggregate social ledger1.
Finally, the assumption of Finite Fine-Grainedness breaks down in the physiological realities of addiction medicine9. While economic and utilitarian models treat welfare transitions across harm-reduction states as smooth, marginal, and continuous, clinical pharmacology exhibits severe discontinuities2. An individual maintained on high-dose agonist therapy experiences an abrupt, non-linear collapse in tolerance upon discontinuation2. When this biological cliff intersects with an illicit drug market dominated by variable, highly potent synthetic opioids, the transition is not a fine-grained decrement in well-being, but an immediate plunge into lethal risk2. Administrative frameworks that treat harm reduction as an incremental scalar continuum fail to account for the catastrophic threshold effects that define treatment interruption1.
System Dynamics and the “Shifting the Burden” Archetype
The inability of MOUD-centric systems to achieve durable, population-level resolution is structural, driven by reinforcing and balancing feedback loops that characterize the “Shifting the Burden” systems archetype2. Under this systemic failure mode, an administrative apparatus implements a symptomatic solution to rapidly suppress a visible problem symptom, which inadvertently attenuates the political, economic, and institutional pressure required to implement fundamental, curative solutions2.
The primary problem symptom consists of surging fatal drug overdoses, emergency department overcrowding, and escalating public disorder2. Health authorities respond through Balancing Loop by lowering barriers to MOUD access, rapidly onboarding individuals onto methadone or buprenorphine2. This immediately relieves visible distress: the acute symptoms of withdrawal are chemically suppressed, cravings are blunted, and the short-term probability of fatal overdose drops substantially2.
However, the fundamental drivers of opioid use disorder operate through Balancing Loop , comprising severe psychological trauma, chronic socioeconomic deprivation, co-morbid mental illness, and a near-total deficit of “recovery capital”—encompassing supportive housing, meaningful employment, family reconciliation, and functional social networks2. Addressing these root drivers requires extensive capital investments, specialized clinical labor, and prolonged, multi-year therapeutic delays2. Because the symptomatic solution of pharmacological buffering () rapidly dampens the visible crisis, the political urgency to fund and sustain the fundamental recovery infrastructure () evaporates2.
This dynamic generates Reinforcing Loop , an unintended side-effect engine that deepens systemic fragility2. Patients develop an absolute physiological and psychological dependence on the institutional intervenor, while public health budgets are captured by recurring medication and dispensing overhead2. Consequently, systemic capacity for comprehensive residential programs, sober-living environments, and intensive psychiatric rehabilitation atrophies2. As the capacity for fundamental recovery withers, patients become increasingly trapped in an escalating reliance on symptomatic containment2.
| Clinical Parameter | Methadone (Full Agonist) | Buprenorphine (Partial Agonist) | Extended-Release Naltrexone (Antagonist) |
| All-Cause Mortality In-Treatment (vs. Out)[cite: 3, 13] | ()3 | ()3 | Limited cohort data; protective while maintained2. |
| Mortality Rate During Active Treatment[cite: 2, 14] | [cite: 2, 14] | [cite: 2, 14] | Highly variable across clinical settings2. |
| Mortality Rate Out-of-Treatment[cite: 2, 14] | [cite: 2, 14] | [cite: 2, 14] | High baseline risk across populations2. |
| Induction Period Mortality Risk (First 4 Weeks)[cite: 3, 13] | () (Accumulation risk)3 | () (Protective ceiling)3 | Elevated risk if precipitated withdrawal occurs2. |
| Post-Cessation Mortality Spike (First 4 Weeks)[cite: 3, 13, 15] | ()3 | ()3 | Elevated due to loss of opioid receptor blockade2. |
| Median Retention Half-Life[cite: 2] | [cite: 2] | [cite: 2] | [cite: 2] |
| Long-Term Treatment Retention (12–18 Months)[cite: 2] | [cite: 2] | [cite: 2] | Substantially lower ()2. |
| Post-Overdose Treatment Uptake (12 Months)[cite: 2] | [cite: 2] | [cite: 2] | [cite: 2] |
The epidemiological consequences of this operational buffering model are acute2. Because MOUD maintains physiological tolerance without repairing underlying social and emotional distress, the intervention lacks a legacy protective effect2. When an individual transitions off active pharmacotherapy, their vulnerability rebounds aggressively2. Epidemiological evidence reveals that in the first four weeks following treatment cessation, all-cause mortality is 6.01 times higher than during active maintenance (; 95% CI: 4.32–8.36)3. Even after this initial four-week window, the mortality rate for the remainder of time out of treatment remains nearly double the in-treatment rate (; 95% CI: 1.50–2.18)3. Overdose-specific mortality out-of-treatment exhibits a rate ratio of 4.80 for methadone (12.7 vs. 2.6 deaths per 1,000 person-years)2.
Compounding this cessation hazard is the induction-phase vulnerability associated with full agonists3. In the first four weeks of methadone treatment, rates of all-cause mortality and drug-related poisoning are nearly double the rates observed during the remainder of treatment (; 95% CI: 1.55–5.09), driven by slow hepatic clearance and drug accumulation3. Conversely, buprenorphine does not exhibit this induction spike (; 95% CI: 0.18–1.85) due to its partial agonist ceiling on respiratory depression3.
Given that median retention durations span only four to five months, and approximately 47% to 48% of patients disengage from care within 12 to 18 months, the buffering strategy continually discharges unstable, non-tolerant individuals back into an illicit drug market dominated by potent synthetic opioids2. The system functions as a high-velocity revolving door, producing transient statistical reductions in mortality while expanding a demographic cohort subject to catastrophic rebound mortality risks2.
Computational Complexity and Social Choice Ruptures in Administrative Governance
The systemic breakdown of utilitarian health governance is further reinforced by formal theorems in social choice theory, computability, and algorithmic mechanism design1. Administrative bodies that attempt to mathematically optimize the allocation of treatment modalities across heterogeneous populations encounter hard theoretical barriers1.
Amartya Sen’s Paradox of the Paretian Liberal demonstrates the mathematical impossibility of reconciling individual liberty with unconstrained Pareto efficiency1. Formally, let a social choice rule satisfy Unrestricted Domain, Weak Pareto, and Condition (Minimal Liberalism), which establishes that at least two distinct individuals are decisive over at least one personal pair of alternatives1. Sen proved that these three conditions are mutually incompatible, inevitably generating cyclical, non-transitive social preference orderings of the form 1.
In public health administration, this paradox manifests when an individual exercises minimal liberalism by choosing to taper off agonist therapy or refusing daily clinic surveillance1. A utilitarian social welfare functional will readily override the patient’s decisive personal sphere whenever an administrative calculation indicates that mandatory pharmacological containment maximizes aggregate public safety and reduces municipal emergency costs1. Conversely, honoring individual autonomy can generate outcomes that are Pareto suboptimal according to collective welfare aggregates1. Within an unconstrained utilitarian SWFL, individual liberty cannot be structurally protected; it is constantly vulnerable to being expropriated whenever the collective utility delta of doing so is positive1.
When administrative agencies attempt to allocate scarce addiction treatment resources based on ordinal preference rankings rather than cardinal sums, they encounter Arrow’s Impossibility Theorem, which proves that any ordinal aggregation rule satisfying Unrestricted Domain, Weak Pareto, and Independence of Irrelevant Alternatives must be dictatorial1.
Furthermore, under the Gibbard-Satterthwaite Theorem, any non-dictatorial ordinal social choice mechanism with three or more distinct alternatives is susceptible to strategic manipulation1. In clinical allocation systems, this guarantees that patients and service providers will strategically misrepresent symptom severity, psychiatric comorbidities, or recovery goals to navigate rationing queues, obtain higher medication allowances, or secure take-home privileges1.
The Mossel-Rácz quantitative boundary establishes that the probability of strategic manipulation under non-dictatorial rules is bounded from below by , where is the number of agents, is the number of alternatives, and represents the distance of the decision rule from a dictatorship1. This formal bound confirms that administrative resource-rationing mechanisms cannot eradicate strategic gaming without resorting to authoritarian institutional control1.
At the computational level, calculating an exact welfare-maximizing allocation across dynamic populations is mathematically intractable1. In combinatorial resource allocation settings—such as matching patients across residential beds, specialty psychotherapy slots, and pharmacological modalities—the social planner’s optimization problem maps to combinatorial auctions or multi-dimensional knapsack problems1. Implementing the classical Vickrey-Clarke-Groves (VCG) mechanism requires computing the socially optimal allocation alongside transfer payments defined by 1. Determining this optimum is -hard and often -hard1.
When administrative bodies deploy polynomial-time approximation algorithms to bypass computational complexity, those heuristics systematically destroy the strategy-proofness of the mechanism, re-opening the system to exploitation1. Finally, under Gödel’s Incompleteness Theorems and Turing’s undecidability results, an automated or algorithmic legal code cannot constructively determine whether an arbitrary administrative policy will terminate in a welfare-maximizing state1. Purely positivistic utilitarian governance is bounded by the intrinsic limits of formal mathematical systems1.
Axiomatic Reconstruction and Institutional Recommendations
To resolve the structural pathologies of the Repugnant Conclusion, dismantle the “Shifting the Burden” feedback loop, and circumvent social choice impossibilities, public health policy must transition away from unconstrained scalar sum-maximization1. Health systems require an axiomatic reconstruction that integrates priority-sensitive welfare orderings, deontological side-constraints, and structural mechanisms that address the delayed dynamics of fundamental recovery1.
Transitioning to the Rawlsian Leximin Principle
Administrative governance must replace the unconstrained total sum with the Rawlsian Leximin (Lexicographic Maximin) principle1. The Leximin framework establishes a distribution-sensitive social ordering that focuses on raising the absolute welfare floor of the least-advantaged individuals rather than inflating the aggregate societal ceiling1. Formally, for any social state , the utility vector is arranged in non-decreasing order1:
A state is socially preferred to state () if and only if there exists some index such that and for all 1.
Operationalizing Leximin requires a fundamental shift in the informational basis of healthcare administration, rejecting Cardinal Unit Comparability (IOU) in favor of Coordinality (CO)1. Under Coordinality, utility transformations take the form , where is a strictly increasing, continuous monotonic transformation common to all agents1.
Coordinality permits meaningful interpersonal comparisons of absolute welfare baselines, enabling public health agencies to systematically identify individuals who exist below an absolute deprivation threshold1. Under this rule, policies that achieve diffuse municipal cost savings by tolerating acute, concentrated mortality risks among patients who drop out of care are strictly impermissible, as they degrade the position of the worst-off individual ()1.
Structuring Rights as Deontological Game Forms
To circumvent Sen’s Paradox of the Paretian Liberal, individual rights must not be modeled as utility arguments within a social welfare functional1. Incorporating rights directly into an aggregate utility ledger leaves them vulnerable to being overridden whenever the net social gain of violating an individual’s autonomy is positive1. Instead, rights must be formulated as deontological game forms that establish constitutional boundaries on the permissible action spaces of administrative agencies1. Formally, a game form is defined as a tuple:
where is the set of agents (patients and clinical institutions), is the strategy set available to agent , is the set of social outcomes, and is the outcome mapping1.
Under this framework, a patient’s entitlement to bodily integrity, informed consent, and uninterrupted access to medical care is safeguarded by ensuring that their private strategy space contains protected actions that the state cannot legally abridge, regardless of the resulting value of 1. Modeling rights as side-constraints rather than preference conditions insulates vulnerable patients from paternalistic containment and prevents the administrative apparatus from sacrificing individual liberty to optimize collective utility1.
Structural Decoupling of Public Health Financing
To dismantle the “Shifting the Burden” dynamic, public healthcare financing must be structurally decoupled from short-term symptomatic throughput metrics2. Conventional reimbursement models tie institutional funding to the sheer volume of medication dispensed and active patient retention tallies, inadvertently rewarding the symptomatic buffer () while neglecting fundamental rehabilitation ()2.
Because fundamental solutions—such as deep trauma psychotherapy, psychiatric stabilization, and the rebuilding of social recovery capital—involve extended therapeutic delays, they are systematically defunded during periods of apparent pharmacological stability2.
Public financing structures must mandate that every public expenditure directed toward low-barrier pharmacological access is matched with a non-fungible capital appropriation reserved strictly for fundamental recovery infrastructure2. This infrastructure must maintain dedicated capacity for intensive residential treatment, specialized dual-diagnosis inpatient units, and structured sober-living communities, ensuring that these comprehensive resources do not atrophy2. By establishing statutory firewall protections around fundamental recovery funding, policymakers ensure that long-term curative capacity is preserved regardless of short-term fluctuations in active pharmacological enrollment2.
Mitigating Transition Hazards and Eliminating the Attrition Cliff
Because all-cause mortality increases 6.01-fold in the four weeks following MOUD cessation, public health systems must treat any involuntary disruption in pharmacological care as a severe institutional failure2. Administrative governance must deploy structural safety nets to eliminate the lethal transition hazard:
| Systemic Failure Point | Causal Mechanism of Vulnerability | Mandatory Statutory and Clinical Remedy |
| Administrative Discharges[cite: 2] | Clinics expel patients for missed appointments, behavioral infractions, or concurrent substance use, precipitating a 6-fold mortality spike2. | Absolute regulatory ban on punitive administrative discharges; mandatory warm-handoff transfers to alternative low-barrier providers without care interruption2. |
| Carceral Interruption[cite: 2, 3] | Incarceration abruptly halts agonist dosing, precipitating tolerance collapse and driving extreme overdose mortality upon release3. | Legally mandated maintenance and initiation of methadone and buprenorphine across all carceral facilities, paired with direct community handoffs upon release2. |
| Insurance Churn and Prior Authorization[cite: 2] | Re-determination delays and pharmacy benefit hurdles create abrupt coverage gaps, forcing unintended pharmacological cessation2. | Statutory implementation of continuous, uninterrupted Medicaid coverage for individuals with OUD; universal prohibition of prior authorization requirements for MOUD2. |
| Methadone Induction Overdose[cite: 3, 13] | Slow hepatic clearance and cumulative dosing increase all-cause mortality by 2.01-fold during the first 4 weeks of methadone titration3. | Prioritize buprenorphine as the primary induction agent due to its favorable safety profile (); deploy telemetry and gradual titration protocols for methadone3. |
| Clinical Re-Entry Barriers[cite: 2] | Patients who disengage face punitive re-admission protocols and lengthy intake delays before resuming medication, elevating out-of-treatment mortality2. | Establishment of immediate, low-threshold, walk-in re-induction protocols across all emergency departments, mobile clinics, and community pharmacies2. |
Conclusion
The intersection of Arrhenius’ axiological impossibility theorems and the clinical realities of Medications for Opioid Use Disorder exposes the structural failure of positivistic, sum-maximizing utilitarianism as a framework for public health governance1. By focusing narrowly on scalar welfare aggregation, administrative systems enact the core pathology of the Repugnant Conclusion: expanding an intervenor-dependent population maintained in states of chronic biological vulnerability and marginal quality of life, while the institutional capacity for fundamental, curative recovery atrophies1.
This dynamic is exacerbated by the “Shifting the Burden” feedback archetype, where the rapid success of pharmacological buffering dampens the systemic urgency to resolve deep psychosocial drivers, creating an operational trap characterized by steep attrition rates and a 6.01-fold spike in post-cessation mortality2.
Escaping these convergent theoretical and empirical pathologies requires dismantling the apparatus of scalar administrative welfarism1. Public health systems must adopt an axiomatic architecture grounded in the Rawlsian Leximin principle, evaluating institutional success by the welfare of the least-advantaged rather than fungible aggregate sums1.
By defining patient autonomy through deontological game forms, structurally shielding fundamental recovery capital from short-term cost-containment pressures, and eliminating institutional transition hazards, health systems can transition away from mere pharmacological containment toward an institutional model that honors human dignity, protects the vulnerable, and fosters durable human flourishing1.
This report was generated by Google Gemini Deep Research using the prompt:
“Write a paper that explains how MOUD falls into some of the problems of the second paper such as Repugnant Conclusion in Arrhenius’ Axiological Impossibilities and provide recommendations”. It was reviewed by Dr. Andrew Sears.
Works cited
- https://drive.google.com/open?id=1BQ6qef3lfZyXIRJ0BNH3E7JmOAGd5bvCmnyALWlvc5I
- https://drive.google.com/open?id=14Wx_06xQa9mr3bvRGODeUvFI6sJzommVTEQr4BjdBY0
- Association of Opioid Agonist Treatment With All-Cause Mortality, https://www.researchgate.net/publication/352071293_Association_of_Opioid_Agonist_Treatment_With_All-Cause_Mortality_and_Specific_Causes_of_Death_Among_People_With_Opioid_Dependence_A_Systematic_Review_and_Meta-analysis
- Future Generations: A Challenge for Moral Theory, https://www.iffs.se/media/23529/fulltext01.pdf
- Chapter 1 The Impossibility of a Satisfactory Population Ethics, https://www.iffs.se/media/2286/the-impossibility-of-a-satisfactory-population-ethics-in-descriptive-and-normative-approaches-to-human-behavior-2011.pdf
- Repugnance without Mere Addition – Tomi Francis, https://tomifrancis.com/docs/repugnance.pdf
- Papers in Population Ethics | Elliott Thornley, https://www.elliott-thornley.com/src/writing/papers-in-population-ethics/
- An Error-Theoretic Response to the Axiological Impossibility Results, https://christophercowie.com/wp-content/uploads/2021/04/an-error-theoretic-response-to-the-axiological-impossibility-results.pdf
- Repugnance without Mere Addition | Economics & Philosophy, https://www.cambridge.org/core/journals/economics-and-philosophy/article/repugnance-without-mere-addition/2E97F364E7E5BD8B498CCAD038B6B15C
- The (im)possibility of prudence: population ethics for person-stages, https://www.cambridge.org/core/services/aop-cambridge-core/content/view/FA4E46CE523F69618C604C4868C1D6C7/S0266267125100643a.pdf/impossibility_of_prudence_population_ethics_for_personstages.pdf
- Calvin Baker (Pohang University of Science and Technology), https://philpeople.org/profiles/calvin-baker
- The Impossibility of a Satisfactory Population Prospect Axiology, https://forum.effectivealtruism.org/posts/5pmweG6xuaCwP6BuB/the-impossibility-of-a-satisfactory-population-prospect
- Opioid Agonist Treatment Linked to Lower Rate of Mortality, Despite, https://www.hcplive.com/view/opioid-agonist-treatment-linked-lower-rate-mortality-limited-access
- Treatment uptake and post-discharge mortality after a policy change, https://www.researchgate.net/publication/410822893_Treatment_uptake_and_post-discharge_mortality_after_a_policy_change_enabling_opioid_agonist_therapy_during_compulsory_care
- Association of Opioid Agonist Treatment With All-Cause Mortality, https://pubmed.ncbi.nlm.nih.gov/34076676/
- The DEA, Telehealth Care, and the Opioid Crisis Author – Reginfo.gov, https://www.reginfo.gov/public/do/eoDownloadDocument?pubId=&eodoc=true&documentID=219292